Inventaire - your friends and communities are your best library

Varenicline in smoking cessation

published in: Expert Review of Respiratory Medicine

date of publication: 2010-06-01

main subject: varenicline

Cites articles 51

Date

Title

Authors

2010-03-22

Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
2010-01-04

Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial

Nancy A Rigotti, Andrew L Pipe
2010-02-13

A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
2010-03-30

Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses.

Matthias Briel, Gordon Guyatt
2010-04-01

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis

Simon J.C. Davies
2010-04-01

Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study
2009-01-01

Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
2009-09-01

Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system

Jean-Pierre Changeux
2009-05-27

Structural and functional diversity of native brain neuronal nicotinic receptors
2009-12-05

The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

Eoin C O'Connor
2009-06-06

Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition
2009-02-20

Varenicline for smoking cessation: a placebo-controlled, randomized study

Chaicharn Pothirat, Simon J.C. Davies
2009-01-01

A preliminary benefit-risk assessment of varenicline in smoking cessation
2009-09-01

Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment
2009-10-01

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

Richard M Martin
2009-01-01

Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study
2009-12-01

Varenicline and suicide. Risk of psychiatric side effects with varenicline
2009-05-01

Engaging the values-based ethical dilemmas in harm minimization: a response to Weatherburn.

Craig L. Fry
2009-02-24

Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline

Gary E Swan, Lisa M. Jack, Jennifer B McClure, Sheryl L Catz, Susan M Zbikowski
2009-01-10

Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect

Marina Picciotto
2009-04-07

Combination treatment with varenicline and nicotine replacement therapy
2008-02-08

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
2008-09-01

Systematic review and meta-analysis of combination therapy for smoking cessation
2007-05-01

Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
2007-06-01

Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
2007-11-21

Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens

Henrike Hartung, Stephanie J Cragg
2007-06-18

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation

Stephen Stahl
2007-03

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
2007-06-01

A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
2007-04-01

A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
2007-11-19

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness
2006-07-01

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial

David Gonzales

Article - wd:Q37762828

Welcome to Inventaire

the library of your friends and communities

learn more